Recombinant Human LRG1 (C-6His)

Description

EnkiLife provides the Recombinant Human LRG1 (C-6His) protein,aslo know as Leucine-rich alpha-2-glycoprotein,HMFT1766,LRG,LRG1, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Leucine-rich Alpha-2-glycoprotein is produced by our Mammalian expression system and the target gene encoding Val36-Gln347 is expressed with a 6His tag at the C-terminus.Accession:AAH34389.1. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:35.4 KDa. Background:Leucine-rich alpha-2-glycoprotein is a secreted protein and contains 8 LRR (leucine-rich) repeats and 1 LRRCT domain. The leucine-rich repeat (LRR) family of proteins, including LRG1, have been shown to be involved in protein-protein interaction, signal transduction, and cell adhesion and development. LRG1 is expressed during granulocyte differentiation. Levels of the LRG protein are markedly elevated in acute appendicitis and therefore could be used as a diagnostic aid.